How Should Technology Vendors Help Steer the Digital Pathology Revolution?
![](https://www.signifyresearch.net/wp-content/uploads/2023/06/Digital-Pathology-Association-Logo-624x429-1-e1714049768345.png)
![Imogen Fitt headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Signify-Imogen_F-Profile-@2-150x150.png)
13th June 2023 – Imogen Fitt – Featured on digitalpathologyassociation.org
Digital pathology (DP) adoption is continuing to scale dramatically, with the global market reporting growth of 37.3%, 31.4% and 27.3% over the last three consecutive years, as shown in Figure 1.
Such growth is, however, relatively new to a market which has been around for decades and only recently started to accelerate in both research and clinical domains.
This is mainly attributable to the effects of COVID-19 in 2020 and the ‚”stay-at-home orders‚” that followed, which prompted an unprecedented shift to remote workflows for pathologists. This served to accentuate the value of DP inherent in utilising digital images for at-home-review and cross-site collaborations; however, what it did not do was address, or even mitigate, the issues previously preventing growth for many years.